Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 7/20 | 0.57 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.57 |
| ▸ | IAPP | P10997 | 3/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | ABL1 | P00519 | 1/20 | 0.54 |
| ▸ | ABL2 | P42684 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10554055 | 1.00 | EGFR (0.57) | EGFRAKR1C3IAPPPTGS1ABL1 | |
| SCHEMBL3423297 | 0.89 | AKR1C3 (0.53) | EGFRAKR1C3IAPPPTGS1ABL1 | |
| SCHEMBL8746634 | 0.89 | AKR1C3 (0.53) | EGFRAKR1C3IAPPPTGS1ABL1 | |
| SCHEMBL9613588 | 0.86 | IAPP (0.56) | EGFRAKR1C3IAPPPTGS1ABL1 | |
| SCHEMBL171076 | 0.85 | AKR1C3 (0.53) | EGFRAKR1C3IAPPPTGS1ABL1 | |
| Methylcaffeate SCHEMBL887921 | 0.84 | APP (0.76) | IAPPPTGS1KDM4EHSD17B10MEN1 | |
| Methylcaffeate SCHEMBL30604508 | 0.84 | APP (0.76) | IAPPPTGS1KDM4EHSD17B10MEN1 | |
| SCHEMBL14086414 | 0.84 | AKR1C3 (0.52) | EGFRAKR1C3IAPPPTGS1ABL1 | |
| SCHEMBL2085780 | 0.84 | AKR1C3 (0.52) | EGFRAKR1C3IAPPPTGS1ABL1 | |
| SCHEMBL2085781 | 0.84 | AKR1C3 (0.52) | EGFRAKR1C3IAPPPTGS1ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112485345-B | Comprehensive analysis method for chemical components of compound antidotal agent of antelope horn | 山东宏济堂制药集团股份有限公司 | 2023-02-17 | — | — | CN | claimed |
| CN-110746302-B | Method for separating and preparing phenolic acid compounds in echinacea purpurea | 山东省分析测试中心 | 2022-04-22 | — | — | CN | claimed |
| CN-110746302-A | Method for separating and preparing phenolic acid compounds in echinacea purpurea | 山东省分析测试中心 | 2020-02-04 | — | — | CN | claimed |
| US-20260096984-A1 | Implantable Device for Administering a Therapeutic Agent | CELANESE EVA PERFORMANCE POLYMERS LLC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260096985-A1 | Injectable Composition For Drug Delivery | CELANESE EVA PERFORMANCE POLYMERS LLC | 2026-04-09 | — | — | US | disclosed |
| US-20260097150-A1 | Implantable Device for Treating an Ocular Condition | CELANESE EVA PERFORMANCE POLYMERS LLC (US) | 2026-04-09 | — | — | US | disclosed |
| CN-117250300-B | Method for detecting multiple components in Tibetan medicine twenty-five-flavor big soup pill | 江西中医药大学 | 2024-02-20 | — | — | CN | disclosed |
| CN-117250300-A | Method for detecting multiple components in Tibetan medicine twenty-five-flavor big soup pill | 江西中医药大学 | 2023-12-19 | — | — | CN | disclosed |
| WO-2023230574-A1 | ENGINEERED PHENYLALANINE AMMONIA LYASE AND TYROSINE AMMONIA LYASE ENZYMES FOR PRODUCING AROMATIC COMPOUNDS | GINKGO BIOWORKS, INC. (US) | 2023-11-30 | — | — | WO | disclosed |
| CN-110746302-B | Method for separating and preparing phenolic acid compounds in echinacea purpurea | 山东省分析测试中心 | 2022-04-22 | — | — | CN | disclosed |
| EP-3328498-B1 | MEDICAL KIT COMPRISING HERBAL COMBINATIONS FOR TREATING PSORIASIS | SIRBAL LTD (CY) | 2021-05-05 | — | — | EP | disclosed |
| WO-2002014497-A2 | GENES ENCODING MUTANT P-COUMARATE 3-HYDROXYLASE (C3H) AND METHODS OF USE | PURDUE RESEARCH FOUNDATION (US) | 2002-02-21 | — | — | WO | disclosed |
| EP-1007743-A2 | ENZYMES MIXTURE | Rhone-Poulenc Animal Nutrition S.A. (FR) | 2000-06-14 | — | — | EP | disclosed |
| WO-1999057325-A2 | ENZYMES MIXTURE | RHONE-POULENC ANIMAL NUTRITION S.A. (FR) | 1999-11-11 | — | — | WO | disclosed |
| US-5426210-A | Water soluble sunscreen agents | SHISEIDO CO., LTD. (JP) | 1995-06-20 | — | — | US | disclosed |
| EP-0539601-A1 | CINNAMIC ACID/GLYCEROL ADDUCT, ULTRAVIOLET ABSORBER, AND DERMATOLOGIC PREPARATION | SHISEIDO COMPANY LIMITED (JP) | 1993-05-05 | — | — | EP | disclosed |
| US-4870019-A | SACCHAROTHRIX | AMERICAN CYANAMID COMPANY (US) | 1989-09-26 | — | — | US | disclosed |
| US-4699790-A | FERMENTATION OF SACCHAROTHRIX EXPANAENSIS | AMERICAN CYANAMID COMPANY (US) | 1987-10-13 | — | — | US | disclosed |
| EP-0051667-B1 | POLYMERS OF POLYKETENE ACETALS AND POLYOLS | SRI INTERNATIONAL (US) | 1986-03-05 | — | — | EP | disclosed |
| US-4304767-A | POLYORTHOESTERS, BIODEGRADATION | SRI INTERNATIONAL (US) | 1981-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097150-A1 | Implantable Device for Treating an Ocular Condition | P4HTM, ITGAM, TIMM44 | EGFR 1011/4885AKR1C3 914/4885IAPP 762/4885 |
| US-20260096984-A1 | Implantable Device for Administering a Therapeutic Agent | GHITM, O60361, P4HTM | EGFR 388/4885AKR1C3 4108/4885IAPP 785/4885 |
| US-20260096985-A1 | Injectable Composition For Drug Delivery | SAMM50, OPRM1, IRAK4 | EGFR 316/4885AKR1C3 1920/4885IAPP 413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.